List of Children's Allegra Allergy drug patents

Children'S Allegra Allergy is owned by Chattem Sanofi.

Children'S Allegra Allergy contains Fexofenadine Hydrochloride.

Children'S Allegra Allergy has a total of 1 drug patent out of which 0 drug patents have expired.

Children'S Allegra Allergy was authorised for market use on 24 January, 2011.

Children'S Allegra Allergy is available in suspension;oral dosage forms.

The generics of Children'S Allegra Allergy are possible to be released after 02 August, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8933097 CHATTEM SANOFI Fexofenadine suspension formulation
Aug, 2030

(7 years from now)

Drugs and Companies using FEXOFENADINE HYDROCHLORIDE ingredient

Market Authorisation Date: 24 January, 2011

Treatment: NA

Dosage: SUSPENSION;ORAL

How can I launch a generic of CHILDREN'S ALLEGRA ALLERGY before it's patent expiration?
More Information on Dosage

CHILDREN'S ALLEGRA ALLERGY family patents

3

United States

1

Portugal

1

Germany

1

Malaysia

1

Uruguay

1

Russia

1

Spain

1

Jordan

1

Brazil

1

Croatia

1

Costa Rica

1

New Zealand

1

Dominican Republic

1

Egypt

1

Norway

1

Austria

1

Argentina

1

Morocco

1

Peru

1

China

1

Taiwan, Province of China

1

Korea, Republic of

1

Hong Kong

1

Honduras

1

Tunisia

1

South Africa

1

Canada

1

Japan

1

Cyprus

1

Slovenia

1

Ukraine

1

Israel

1

Poland

1

Australia

1

RS

1

Ecuador

1

Denmark

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic